Authors:
- prof. dr hab. n. med. Adrian Doroszko
- prof. dr hab. n. med. Piotr Dobrowolski
- prof. dr hab. n. med. Aleksander Prejbisz
Keywords: dihydropiridine-calcium channel blockers, DHP- -CCB, lercanidipine, arterial hypertension, chronic coronary syndrome, efficacy, side effects